š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The primary purpose of this study is to evaluate the persistence of bacteri...
Status
Completed
Location
Dr. Johannes Kandzora and Dr. Kathrin Kandzora
Start Date
2011-05
Trial ID
NCT01345721
Treatments Being Tested
The primary immunogenicity objective is to assess and compare the immunogen...
Status
Completed
Location
Site 22
Start Date
2008-03
Trial ID
NCT00667602
Treatments Being Tested
This safety surveillance study of GlaxoSmithKline's quadrivalent meningococ...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-12-01
Trial ID
NCT02287688
Treatments Being Tested
This study will evaluate the immunogenicity, reactogenicity and safety of a...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2017-08-01
Trial ID
NCT03189745
Treatments Being Tested
The purpose of the study was to assess the immunogenicity and safety of two...
Status
Completed
Location
06 Kosin University Gospel Hospital 34, amnam-dong
Start Date
2013-11
Trial ID
NCT01973218
The need for and timing of booster doses of meningococcal vaccines in Peopl...
Status
Unknown
Location
St George's University of London
Start Date
2020-11-26
Trial ID
NCT04239430
Treatments Being Tested
The purpose of this study is to summarize the occurrence of incident seriou...
Status
Completed
Location
Kaiser Permanente South California
Start Date
2011-09
Trial ID
NCT01452438
Treatments Being Tested
The purpose of this study is to evaluate the safety, immunogenicity and ind...
Status
Completed
Location
Vaccine Evaluation Center
Start Date
2004-09
Trial ID
NCT00262002
Treatments Being Tested
This study will evaluate the immunogenicity and safety of a single injectio...
Status
Completed
Location
Mackay Memorial Hospital,
Start Date
2011-08
Trial ID
NCT01410474
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976